REITWAVE.COM Institutional Equity Tear Sheet Generator
Download Vector PDF Export Model (CSV)
REITWAVE.COM | INSTITUTIONAL REAL ESTATE RESEARCH
AS OF: OCTOBER 24, 2026  |  10Y TREASURY: 4.99%  |  SIC 6798

Healthcare Realty Trust Inc ($HR)

Sector: Healthcare Facilities  •  Exchange / CIK: NYSE / 0001360604  •  Properties: 150 Assets
Trading at a 8.3% discount to NAV
Safety Score: 72/100 (Moderate Risk)  |  Credit: BBB

Live Share Price

$17.95
52W Range: $16.31 - $22.04

Valuation Multiples

14.0x P/AFFO
P/FFO: 13.0x  |  FFO/sh: $1.38

Net Asset Value (NAV)

$19.57
Prem/Disc: -8.3%  |  Cap: 6.54%

Dividend Cash Flow

5.57% Yield
$1.00/yr (Quarterly)  |  Payout: 78.1%
Balance Sheet & Debt Maturity Sentry
Net Debt to EBITDAre stands at 5.6x. Portfolio leased occupancy is 90.0% with a weighted average lease term (WALT) of 6.5 years. Senior credit rating of BBB provides institutional capital markets access for debt refinancing.
Recent Dividend Payment History (Last 6 Declarations)
Ex-Dividend Date Record / Pay Date Cash Distribution Status / Corporate Action
2026-09-30 2026-10-15 $0.2500 Regular Distribution
Representative Commercial Asset Concentrations (From SEC Form 10-K Item 2)
Commercial Asset / Property Name Location Rentable Sq Ft Occupancy Implied Asset Valuation
Healthcare Realty Trust Inc Flagship Commercial Portfolio United States Nationwide 18,750,000 sq ft (implied) 90.0% $2,935,500,000
Quantitative Risk & Benchmark Performance (QuantStats • VNQ)
Empirical 252-day trading window compared to Vanguard Real Estate ETF (VNQ) benchmark
METHODOLOGY: QUANTSTATS / CAPM
Beta vs VNQ
0.96
Index Tracking (Market Neutral)
Annualized Alpha (α)
-1.65%
Trailing VNQ
Sharpe Ratio (vs VNQ)
-0.07 vs 0.04
-0.11 Spread
Max Drawdown (1-Yr)
-21.9% vs -11.4%
-10.5% vs VNQ
HR vs VNQ QuantStats Performance & Underwater Drawdown
Quantitative Risk & Return Metric HR VNQ (Benchmark) Institutional Delta / Spread
Beta (β) vs VNQ
Covariance sensitivity to US REIT market
0.96 1.00 -0.04 (Index Tracking (Market Neutral))
Annualized Alpha (α)
Excess CAPM risk-adjusted performance
-1.65% 0.00% (Baseline) Trailing VNQ
Sharpe Ratio (Rf = 4.5%)
Annualized excess return per unit of volatility
-0.07 0.04 -0.11
Sortino Ratio
Downside semi-variance risk-adjusted return
-0.07 0.03 -0.10
Annualized Volatility (σ)
Standard deviation of daily price returns × √252
19.8% 13.9% +5.9% (Higher Volatility)
Maximum Drawdown (1-Year)
Peak-to-trough capital decline over trailing 12M
-21.9% -11.4% -10.5% vs VNQ
1-Year Trailing Return (CAGR)
Compounded annual growth rate
1.2% 4.1% -2.9% Spread
R-Squared (R²) & Correlation
Statistical correlation coefficient against VNQ
R² 0.46 Corr: 0.68 46% variance explained by VNQ
Trading Session Win Rate
Percentage of positive daily closing sessions
48.4% 51.6% -3.2% vs Benchmark
QuantStats Analytical Synthesis: HR displays a Beta of 0.96 relative to VNQ with 0.46 R² correlation. Annualized volatility is 19.8% (5.9% higher than VNQ at 13.9%). Trailing 12-month Alpha stands at -1.65% (Trailing VNQ) with a Sharpe ratio of -0.07 against 0.04 for VNQ, and a maximum drawdown of -21.9%.
SEC CIK: 0001360604  |  Principal Executive Officer: Executive Leadership / Healthcare Corp  |  Total PEO Compensation: Reported in DEF 14A (N/A)
Official SEC Accession: 0001360604-26-000001
CONFIDENTIAL INSTITUTIONAL TEAR SHEET • REITWAVE.COM (v1.0.0) • Data Sources: SEC EDGAR Form 10-K / DEF 14A, PR Newswire, Bloomberg/CBRE Comps. For institutional and accredited investor due diligence. Not a solicitation or investment recommendation.